The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Relevance of bone marrow biopsies for response assessment in NCTN follicular lymphoma clinical trials.
 
Sarah C. Rutherford
Consulting or Advisory Role - AstraZeneca; BeiGene; Celgene; HERON; Juno Therapeutics; Karyopharm Therapeutics; Seagen; Verastem
Research Funding - Genentech (Inst); Karyopharm Therapeutics (Inst); LAM Therapeutics (Inst); Regeneron (Inst); Roche/Genentech (Inst)
 
Jun Yin
Employment - Mayo Clinic
 
Levi Pederson
No Relationships to Disclose
 
Betsy LaPlant
No Relationships to Disclose
 
Mazyar Shadman
Consulting or Advisory Role - Abbvie; ADC Therapeutics; AstraZeneca; Atara Biotherapeutics; Cellectar; Genentech; Sound Biologics; Verastem
Research Funding - Abbvie (Inst); Acerta Pharma (Inst); BeiGene (Inst); Celgene (Inst); Emergent BioSolutions (Inst); Genentech (Inst); Gilead Sciences (Inst); Merck (Inst); MustangBio (Inst); Pharmacyclics (Inst); Sunesis Pharmaceuticals (Inst); TG Therapeutics (Inst)
 
Hongli Li
No Relationships to Disclose
 
Michael Leo LeBlanc
Consulting or Advisory Role - Agios
 
Kristie A. Blum
Research Funding - Acerta Pharma
 
Travis Dockter
No Relationships to Disclose
 
Peter Martin
Consulting or Advisory Role - Bayer; BeiGene; Celgene; Cellectar; I-Mab; Janssen; Karyopharm Therapeutics; Karyopharm Therapeutics; Kite, a Gilead company; MorphoSys; Sandoz; TeneoBio
Research Funding - Karyopharm Therapeutics (Inst)
Travel, Accommodations, Expenses - Janssen
 
Sin-Ho Jung
Consulting or Advisory Role - Samsung
 
Barbara W. Grant
No Relationships to Disclose
 
Cara Ann Rosenbaum
No Relationships to Disclose
 
Chaitra Shankar Ujjani
Honoraria - Abbvie; AstraZeneca; Atara Biotherapeutics; Bayer; Genentech; Kite/Gilead; Pharmacyclics; RadMD; Verastem
Consulting or Advisory Role - AstraZeneca
Research Funding - Abbvie (Inst); Pharmacyclics (Inst)
 
Paul M. Barr
Consulting or Advisory Role - Abbvie; AstraZeneca; Celgene; Genentech; Infinity Pharmaceuticals; Janssen; Merck; MorphoSys; Novartis; Pharmacyclics; Seagen; TG Therapeutics
Research Funding - AstraZeneca (Inst); Pharmacyclics (Inst)
 
Joseph M. Unger
No Relationships to Disclose
 
Bruce D. Cheson
Consulting or Advisory Role - Abbvie; Astellas Pharma; AstraZeneca; Bayer; Celgene; Epizyme; Gilead Sciences; Karyopharm Therapeutics; Morphosys; Parexel; Pharmacyclics/Janssen; Roche/Genentech; SymBio Pharmaceuticals; TG Therapeutics
Research Funding - Abbvie (Inst); Acerta Pharma (Inst); Bristol-Myers Squibb (Inst); Gilead Sciences (Inst); Gilead Sciences (Inst); Roche/Genentech (Inst); Seagen (Inst); TG Therapeutics (Inst); Trillium Therapeutics (Inst)
Travel, Accommodations, Expenses - SymBio Pharmaceuticals
 
Nancy L. Bartlett
Consulting or Advisory Role - Seagen
Research Funding - ADC Therapeutics (Inst); Autolus (Inst); Bristol-Myers Squibb (Inst); Celgene (Inst); Forty Seven (Inst); Genentech (Inst); Immune Design (Inst); Janssen (Inst); Kite, a Gilead company (Inst); Merck (Inst); Millennium (Inst); Pharmacyclics (Inst); Seagen (Inst)
 
Jonathan W. Friedberg
Consulting or Advisory Role - Astellas Pharma; Bayer; Portola Pharmaceuticals
Research Funding - Kite, a Gilead company (Inst); Seagen (Inst)
Patents, Royalties, Other Intellectual Property - Patient on bone marrow microenvironment signals (I)
Travel, Accommodations, Expenses - Roche
 
John Paul Leonard
Consulting or Advisory Role - ADC Therapeutics; Akcea Therapeutics; AstraZeneca; Bayer; Bayer; Bristol-Myers Squibb; Celgene; Epizyme; Genentech/Roche; Gilead Sciences; Karyopharm Therapeutics; MEI Pharma; Merck; Miltenyi Biotec; Morphosys; Nordic Nanovector; Nordic Nanovector; Regeneron; Sandoz; Sutter Medical Group
Research Funding - Alliance for Clinical Trials in Oncology (Inst); Celgene (Inst); Janssen Oncology (Inst); National Cancer Institute (Inst); Pfizer (Inst); Takeda (Inst)
Travel, Accommodations, Expenses - BeiGene